To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SRRTTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
475 representative clones for gene SRRT back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW194851 Kidney .a 1 to 318 318 to 1   tiling clone,   318/318
(100 %)
0 diff
(100 %id)
NM_015908.5   .a 114 to 3126 1 to 3014 exact RefSeq, AAA   3014/3014
(100 %)
1 diff
(100.0 %id)
BC109116 PCR rescued clones .a 223 to 3126 1 to 2904 G104V G106A P107Q T108L Y109M ... tiling clone,   2904/2905
(99 %)
3 diff
(99.9 %id)
BI043783 ovary .a 312 to 572 260 to 1   tiling clone,   265/260
(101 %)
8 diff
(97.0 %id)
BC069249 Brain, astrocytoma, grade IV .a 572 to 3126 1 to 2555   tiling clone, available from MGC, AAA   2555/2555
(100 %)
1 diff
(100.0 %id)
AF112994   .a 2083 to 3126 151 to 1199       1049/1204
(87 %)
12 diff
(99.1 %id)
BU589368 mixed (pool of 40 RNAs) .a 2204 to 3049 27 to 883       857/896
(95 %)
21 diff
(97.7 %id)
TI_149297322   .a 2208 to 3126 983 to 86   AAA   898/963
(93 %)
22 diff
(97.8 %id)
TI_149307258   .a 2250 to 3124 960 to 91   AAA   870/987
(88 %)
16 diff
(98.4 %id)
DR158423 human embryonic stem cells differentiated toan early endodermal cell type .a 2306 to 3113 808 to 1     Submitted on the opposite strand 808/808
(100 %)
0 diff
(100 %id)
TI_149303648   .a 2318 to 3125 878 to 83   AAA   800/926
(86 %)
17 diff
(98.2 %id)
AA630410   .a 2319 to 3126 808 to 6       803/808
(99 %)
15 diff
(98.2 %id)
BM551921 melanotic melanoma, skin .a 2328 to 3126 1 to 803   AAA   803/803
(100 %)
8 diff
(99.1 %id)
BM053118 Islets of Langerhans, Pancreas .a 2343 to 2772 1 to 430   fully sequenced,   430/430
(100 %)
0 diff
(100 %id)
TI_149297762   .a 2349 to 3126 823 to 55   AAA   769/972
(79 %)
10 diff
(99.0 %id)
TI_149296100   .a 2354 to 3126 875 to 111   AAA   765/900
(85 %)
11 diff
(98.8 %id)
CN421982 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2357 to 3092 1 to 736       736/736
(100 %)
1 diff
(99.9 %id)
TI_154101512   .a 2360 to 3126 847 to 91   AAA   757/784
(96 %)
9 diff
(98.9 %id)
BQ068646 brain, neuroblastoma, cell line .a 2372 to 3127 1 to 756   AAA   756/756
(100 %)
3 diff
(99.7 %id)
BM981619 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2380 to 3125 759 to 19   AAA   741/741
(100 %)
6 diff
(99.2 %id)
BQ674559 epidermoid carcinoma, cell line, salivary gland .a 2385 to 3127 1 to 743       743/939
(79 %)
5 diff
(99.5 %id)
BM821628 stomach .a 2389 to 2947 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
CX758629 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2391 to 3126 769 to 44   AAA   726/726
(100 %)
24 diff
(96.7 %id)
CA443853 Fibrosarcoma .a 2395 to 3126 749 to 19   AAA   731/731
(100 %)
1 diff
(99.9 %id)
CD370406 Alveolar Macrophage, lung .a 2395 to 3126 746 to 19   AAA   728/728
(100 %)
4 diff
(99.5 %id)
CX872505 embryonic stem .a 2396 to 3126 773 to 43   AAA Submitted on the opposite strand 731/731
(100 %)
8 diff
(99.0 %id)
CA441959 Chondrosarcoma, Left Pubic Bone .a 2413 to 3126 729 to 19   AAA   711/711
(100 %)
3 diff
(99.6 %id)
BM982776 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2422 to 3126 721 to 19   AAA   703/703
(100 %)
4 diff
(99.5 %id)
BM982406 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2422 to 3126 720 to 19   AAA   702/702
(100 %)
3 diff
(99.6 %id)
CA307449 Alveolar Macrophage, lung .a 2422 to 3127 723 to 19   tiling clone, AAA   705/705
(100 %)
1 diff
(99.9 %id)
CB854784 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2427 to 3126 718 to 19   AAA   700/700
(100 %)
5 diff
(99.3 %id)
BQ008891 Chondrosarcoma, Left Pelvis .a 2435 to 3126 706 to 19   AAA   688/688
(100 %)
4 diff
(99.5 %id)
CV812228 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2440 to 3126 725 to 42   AAA Submitted on the opposite strand 684/685
(99 %)
9 diff
(98.7 %id)
BU686756 lung, Primary Lung Epithelial Cells .a 2448 to 3124 694 to 17   AAA   678/678
(100 %)
1 diff
(99.9 %id)
CD367768 Alveolar Macrophage, lung .a 2452 to 3126 693 to 19   AAA   675/675
(100 %)
0 diff
(100 %id)
AI524314 Prostate .a 2457 to 3126 676 to 7       670/679
(98 %)
9 diff
(98.7 %id)
BQ010436 Chondrosarcoma, Left Pubic Bone .a 2457 to 3126 687 to 19   AAA   669/669
(100 %)
3 diff
(99.6 %id)
BU630537 cell lines, Chondrosarcoma .a 2457 to 3126 686 to 19   AAA   668/668
(100 %)
2 diff
(99.8 %id)
AA621657   .a 2460 to 3126 681 to 14   AAA   668/668
(100 %)
21 diff
(96.9 %id)
DB519614 testis .a 2461 to 3126 1 to 663     Submitted on the opposite strand 663/663
(100 %)
7 diff
(99.0 %id)
CB119348 Liver .a 2474 to 2990 1 to 517       517/517
(100 %)
0 diff
(100 %id)
DB526988 testis .a 2480 to 3124 1 to 645     Submitted on the opposite strand 645/647
(99 %)
2 diff
(99.7 %id)
BQ003547 Chondrosarcoma, Left Pelvis .a 2481 to 3126 664 to 19   AAA   646/646
(100 %)
0 diff
(100 %id)
BM796894 Ascites, stomach .a 2498 to 2989 1 to 492       492/492
(100 %)
0 diff
(100 %id)
AI436591 B-cell, chronic lymphotic leukemia .a 2520 to 3126 609 to 3       607/609
(99 %)
0 diff
(100 %id)
AA573867 colon, tumor .a 2529 to 3126 598 to 2       597/598
(99 %)
3 diff
(99.5 %id)
CA427406 Cell Line, Chondrosarcoma .a 2532 to 3126 618 to 19   AAA   599/600
(99 %)
12 diff
(98.0 %id)
AI479743 anaplastic oligodendroglioma, brain .a 2549 to 3126 593 to 16   AAA   578/607
(95 %)
11 diff
(98.2 %id)
CK903947 Islets of Langerhans, Pancreas .a 2553 to 3126 580 to 7       574/580
(98 %)
0 diff
(100 %id)
BM052744 Islets of Langerhans, Pancreas .a 2556 to 3126 577 to 7       571/577
(98 %)
0 diff
(100 %id)
AI004763   .a 2577 to 3126 561 to 14   AAA   548/548
(100 %)
13 diff
(97.7 %id)
BQ953165 eye, normal pigmented retinal epithelium .a 2578 to 3130 1 to 556   AAA   556/598
(92 %)
3 diff
(99.5 %id)
BY997291   .a 2579 to 3126 600 to 53   AAA Submitted on the opposite strand 548/548
(100 %)
1 diff
(99.9 %id)
BU617721 Bone, Subchondral Bone .a 2579 to 3126 565 to 18   AAA   548/550
(99 %)
5 diff
(99.1 %id)
BM997332 lung, Metastatic Chondrosarcoma .a 2585 to 3126 559 to 19   AAA   541/541
(100 %)
2 diff
(99.7 %id)
DB371002 ovary, tumor tissue .a 2593 to 3126 531 to 1       531/534
(99 %)
15 diff
(97.2 %id)
BM726242 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2603 to 3126 1 to 524   fully sequenced,   524/524
(100 %)
1 diff
(99.9 %id)
AI936189 normal prostate, Prostate .a 2612 to 3126 519 to 6       514/519
(99 %)
9 diff
(98.3 %id)
AW439611 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2613 to 3126 517 to 4       514/544
(94 %)
25 diff
(95.5 %id)
BG030779 breast, mammary adenocarcinoma, cell line .a 2614 to 3126 1 to 513   AAA   513/513
(100 %)
1 diff
(99.9 %id)
AW966580   .a 2632 to 3126 1 to 504       504/540
(93 %)
35 diff
(93.6 %id)
AA262740 germinal center B cell .a 2639 to 2839 1 to 205   fully sequenced,   204/204
(100 %)
5 diff
(97.6 %id)
AW967975   .a 2640 to 3126 1 to 486       486/572
(84 %)
3 diff
(99.5 %id)
AA431392   .a 2644 to 3095 1 to 452       452/452
(100 %)
4 diff
(99.2 %id)
CA307667 Alveolar Macrophage, lung .a 2651 to 3126 496 to 19   AAA   478/478
(100 %)
2 diff
(99.6 %id)
BE207984 muscle, rhabdomyosarcoma .a 2655 to 3126 492 to 21   AAA   472/472
(100 %)
0 diff
(100 %id)
AA976272 Kidney, kidney tumor .a 2658 to 3097 439 to 1       439/439
(100 %)
5 diff
(98.9 %id)
DR157316 human embryonic stem cells differentiated toan early endodermal cell type .a 2666 to 3126 490 to 30   AAA Submitted on the opposite strand 461/461
(100 %)
1 diff
(99.8 %id)
AI797184 colon .a 2674 to 3126 451 to 4       449/451
(99 %)
8 diff
(98.3 %id)
AI753288 bone marrow stroma .a 2677 to 3126 468 to 19   AAA   450/450
(100 %)
1 diff
(99.8 %id)
AI041321   .a 2677 to 3126 457 to 13   AAA   447/445
(100 %)
14 diff
(96.9 %id)
DB512368 testis .a 2707 to 3125 7 to 424     Submitted on the opposite strand 418/424
(98 %)
4 diff
(99.1 %id)
AA505843 breast .a 2707 to 3126 426 to 7       420/436
(96 %)
6 diff
(98.7 %id)
AI767085 2 pooled tumors (clear cell type), Kidney .a 2707 to 3126 421 to 2       420/431
(97 %)
0 diff
(100 %id)
BX362453   .a 2710 to 3126 1 to 417       417/417
(100 %)
4 diff
(99.1 %id)
AW439635 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2712 to 3126 418 to 4       415/418
(99 %)
3 diff
(99.3 %id)
BF221928 Prostate .a 2713 to 3125 430 to 18   AAA   413/462
(89 %)
11 diff
(97.7 %id)
AA405856.
matches multiple genes
  .a 2718 to 3125 410 to 5     also hits gene zoder 406/418
(97 %)
1 diff
(99.8 %id)
AA833915 Kidney, kidney tumor .a 2718 to 3126 410 to 5       406/418
(97 %)
3 diff
(99.3 %id)
AA419584 germinal center B cell .a 2721 to 3126 409 to 4     Submitted on the opposite strand 406/411
(98 %)
0 diff
(100 %id)
R73443 breast .a 2734 to 3090 56 to 419   fully sequenced,   364/419
(86 %)
21 diff
(95.0 %id)
DR157758 human embryonic stem cells differentiated toan early endodermal cell type .a 2735 to 3125 415 to 25   AAA Submitted on the opposite strand 391/391
(100 %)
3 diff
(99.3 %id)
AA621689   .a 2741 to 3126 397 to 15   AAA   383/383
(100 %)
8 diff
(98.0 %id)
BM052807 Islets of Langerhans, Pancreas .a 2742 to 3126 391 to 7   fully sequenced,   385/391
(98 %)
0 diff
(100 %id)
AI918762 pooled germ cell tumors .a 2757 to 3126 377 to 8       370/377
(98 %)
0 diff
(100 %id)
CF529899 placenta .a 2773 to 3126 372 to 19   AAA   354/354
(100 %)
0 diff
(100 %id)
AI362769 anaplastic oligodendroglioma, brain .a 2775 to 3125 352 to 2       351/352
(99 %)
0 diff
(100 %id)
AA262726 germinal center B cell .a 2778 to 3126 363 to 15   fully sequenced, AAA   349/349
(100 %)
0 diff
(100 %id)
BM680853 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2778 to 3126 367 to 19   fully sequenced, AAA   349/349
(100 %)
0 diff
(100 %id)
CN421978 embryonic stem cells, DMSO-treated H9 cellline .a 2779 to 3126 358 to 11   AAA Submitted on the opposite strand 348/348
(100 %)
1 diff
(99.8 %id)
AW044494 Kidney .a 2780 to 3126 349 to 2       348/349
(99 %)
3 diff
(99.2 %id)
AA503153 ovary .a 2807 to 3126 333 to 14   AAA   320/326
(98 %)
1 diff
(99.7 %id)
AI193299 lung .a 2807 to 3126 324 to 5       320/342
(93 %)
6 diff
(98.3 %id)
AA853765 Bone, Hip .a 2812 to 3105 299 to 6       294/299
(98 %)
0 diff
(100 %id)
AI203223 pooled germ cell tumors .a 2815 to 3126 313 to 1       313/313
(100 %)
2 diff
(99.4 %id)
CN421986 embryonic stem cells, DMSO-treated H9 cellline .a 2820 to 3126 317 to 11   AAA Submitted on the opposite strand 307/307
(100 %)
5 diff
(98.4 %id)
AA016143 heart .a 2852 to 3126 279 to 1       279/298
(93 %)
8 diff
(97.4 %id)
AA078496 placenta .a 2868 to 3125 258 to 1       258/258
(100 %)
0 diff
(100 %id)
G30851   .a 2868 to 3125 258 to 1     Submitted on the opposite strand 258/258
(100 %)
0 diff
(100 %id)
N47024 placenta .a 2872 to 3126 259 to 5     Submitted on the opposite strand 255/259
(98 %)
0 diff
(100 %id)
BU588675 mixed (pool of 40 RNAs) .a 2889 to 3125 1 to 237   AAA   237/237
(100 %)
1 diff
(99.6 %id)
AI203376 pooled germ cell tumors .a 2924 to 3126 203 to 1       203/203
(100 %)
0 diff
(100 %id)
AI824806 pooled germ cell tumors .a 2924 to 3126 203 to 1       203/203
(100 %)
0 diff
(100 %id)
AA506735 Prostate .a 2932 to 3126 13 to 207   AAA   195/207
(94 %)
6 diff
(97.2 %id)
R73444 breast .a 2953 to 3114 174 to 12   fully sequenced,   163/174
(93 %)
1 diff
(99.5 %id)
R88549 brain .a 2955 to 3125 172 to 2     Submitted on the opposite strand 171/172
(99 %)
0 diff
(100 %id)
AW023553 cochlea, ear .a 2959 to 3125 1 to 167       167/188
(88 %)
6 diff
(96.9 %id)
AA505783 breast .a 2994 to 3126 141 to 9       133/141
(94 %)
0 diff
(100 %id)
CA337167 posterior rhombomeres 5-8 (4 pooled) .a 2994 to 3126 1 to 134   AAA   134/134
(100 %)
1 diff
(99.3 %id)
EC519716 Prostate .a 3011 to 3120 1 to 111       111/111
(100 %)
4 diff
(96.4 %id)
NM_001128852.1   .b 1 to 3010 1 to 3011 exact RefSeq, AAA   3011/3011
(100 %)
1 diff
(100.0 %id)
AL096723 brain .b 47 to 3010 1 to 2965 G105W T108N Y109L G110W Q113S ... tiling clone, available from DKFZ, AAA   2965/2965
(100 %)
10 diff
(99.7 %id)
BE019304 muscle, rhabdomyosarcoma .b 189 to 580 1 to 393       393/393
(100 %)
1 diff
(99.8 %id)
BI261827 lymph, lymphoma, cell line .b 433 to 888 1 to 456       456/675
(67 %)
8 diff
(98.9 %id)
BI085569 astrocytoma grade IV, cell line, brain .b 458 to 1053 1 to 598   tiling clone,   598/607
(98 %)
7 diff
(98.9 %id)
AK296131 thalamus .b 1031 to 3010 1 to 1980   tiling clone,   1980/1980
(100 %)
2 diff
(99.9 %id)
BG682911 brain, neuroblastoma, cell line .b 1115 to 1907 1 to 792       792/792
(100 %)
6 diff
(99.3 %id)
BC000082 Kidney, renal cell adenocarcinoma .b 1476 to 3010 1 to 1535   available from MGC, AAA   1535/1535
(100 %)
0 diff
(100 %id)
H16604 whole brain .b 1662 to 2070 1 to 417       417/464
(89 %)
12 diff
(97.5 %id)
CR610730 Neuroblastoma Cot 25-normalized .b 1778 to 2967 1 to 1190       1190/1190
(100 %)
0 diff
(100 %id)
AL525674 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1778 to 2464 1 to 687   fully sequenced,   687/687
(100 %)
1 diff
(99.9 %id)
BM552596 astrocytoma grade IV, cell line, brain .b 1882 to 2761 1 to 887       887/1032
(85 %)
9 diff
(99.2 %id)
BG750935 eye, normal pigmented retinal epithelium .b 2022 to 2818 1 to 795   AAA   793/977
(81 %)
25 diff
(97.5 %id)
BG751720 eye, normal pigmented retinal epithelium .b 2022 to 2667 1 to 647       647/653
(99 %)
8 diff
(98.8 %id)
BG289024 bladder, transitional cell papilloma, cell line .b 2067 to 2641 1 to 574       574/577
(99 %)
11 diff
(98.1 %id)
BI194292 epithelioid carcinoma cell line, Pancreas .b 2087 to 2818 1 to 756       716/814
(87 %)
58 diff
(92.9 %id)
BE796729 lung, small cell carcinoma .b 2112 to 2740 1 to 626       626/631
(99 %)
3 diff
(99.6 %id)
AW963389   .b 2138 to 2774 1 to 639       639/639
(100 %)
14 diff
(97.9 %id)
BY797903 eye .b 2171 to 2724 1 to 554       554/554
(100 %)
0 diff
(100 %id)
CB986925 Pooled-Glandular .b 2209 to 2825 1 to 624       622/768
(80 %)
11 diff
(98.6 %id)
CK903948 Islets of Langerhans, Pancreas .b 2212 to 2800 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BM053021 Islets of Langerhans, Pancreas .b 2228 to 2820 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BP429639   .b 2228 to 2618 6 to 396       391/396
(98 %)
0 diff
(100 %id)
BE743393 adenocarcinoma cell line, ovary .b 2295 to 2631 335 to 1     Submitted on the opposite strand 335/832
(40 %)
2 diff
(99.8 %id)
BG683617 brain, neuroblastoma, cell line .b 2296 to 2966 673 to 1       673/673
(100 %)
7 diff
(99.0 %id)
BI262497 lymph, lymphoma, cell line .b 2299 to 2940 664 to 18       647/664
(97 %)
9 diff
(98.7 %id)
D61681   .b 2336 to 2689 1 to 347       347/347
(100 %)
9 diff
(97.5 %id)
BE163556 head_neck .b 2348 to 2726 398 to 21     Submitted on the opposite strand 378/398
(94 %)
1 diff
(99.8 %id)
BI086059 astrocytoma grade IV, cell line, brain .b 2350 to 2939 617 to 2       616/645
(95 %)
38 diff
(94.2 %id)
CB121113 Liver .b 2360 to 2783 1 to 420       420/420
(100 %)
8 diff
(98.1 %id)
AL525626 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 2403 to 2967 565 to 1   fully sequenced,   565/565
(100 %)
1 diff
(99.9 %id)
AW384163 head_neck .b 2410 to 2948 544 to 5       535/544
(98 %)
11 diff
(98.0 %id)
AW384196 head_neck .b 2410 to 2948 544 to 5       535/544
(98 %)
11 diff
(98.0 %id)
BI013574 lung_tumor .b 2421 to 2644 226 to 4       223/226
(98 %)
0 diff
(100 %id)
AA384758 thyroid gland .b 2501 to 2726 1 to 226       226/226
(100 %)
1 diff
(99.6 %id)
BE207971 muscle, rhabdomyosarcoma .b 2542 to 3010 489 to 21   AAA   469/469
(100 %)
0 diff
(100 %id)
H16563 whole brain .b 2594 to 3010 433 to 13   AAA   419/436
(96 %)
7 diff
(98.4 %id)
NM_001128853.1   .c 1 to 3001 1 to 3002 exact RefSeq, AAA   3002/3002
(100 %)
1 diff
(100.0 %id)
AF248955   .c 39 to 3001 1 to 2965 G105W T108N Y109L G110W Q113S ... tiling clone, AAA   2965/2965
(100 %)
7 diff
(99.8 %id)
BX505829   .c 854 to 1524 1 to 671       671/671
(100 %)
2 diff
(99.8 %id)
BG341374 B-cells, primary B-cells from tonsils (cell line) .c 872 to 1522 1 to 659       659/1176
(56 %)
19 diff
(98.4 %id)
BE513568 Burkitt lymphoma, lymph .c 924 to 1441 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
AW043701 pooled .c 975 to 1461 487 to 1       487/487
(100 %)
1 diff
(99.8 %id)
AW027695 thymus, pooled .c 994 to 1507 514 to 1   tiling clone,   514/514
(100 %)
1 diff
(99.9 %id)
DB204192 trachea .c 994 to 1570 2 to 579   capped   578/578
(100 %)
4 diff
(99.4 %id)
BE796566 lung, small cell carcinoma .c 1000 to 1693 1 to 691       691/691
(100 %)
4 diff
(99.5 %id)
DA264039 caudate nucleus .c 1026 to 1564 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
AA514369 colon .c 1046 to 1461 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
CB152228 brain .c 1047 to 1610 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
CD673784 eye, lens .c 1082 to 1517 446 to 11     Submitted on the opposite strand 436/446
(97 %)
0 diff
(100 %id)
DB101894 thymus .c 1121 to 1672 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BF515633   .c 1153 to 1515 363 to 1       363/363
(100 %)
0 diff
(100 %id)
AA077711 brain .c 1155 to 1458 1 to 299       299/299
(100 %)
3 diff
(99.0 %id)
BQ642046 lymph, lymphoma, cell line .c 1167 to 2085 1 to 921       921/925
(99 %)
20 diff
(97.9 %id)
BI160560 epithelioid carcinoma cell line, Pancreas .c 1171 to 1959 1 to 790       794/790
(100 %)
19 diff
(97.6 %id)
DA937615 Spleen .c 1172 to 1778 2 to 609   capped   608/608
(100 %)
2 diff
(99.7 %id)
BE792827 lung, small cell carcinoma .c 1174 to 2026 1 to 851       853/909
(93 %)
16 diff
(98.3 %id)
BQ681993 melanotic melanoma, cell line, skin .c 1185 to 2049 1 to 869       869/938
(92 %)
16 diff
(98.3 %id)
BG437503 large cell carcinoma, lung .c 1193 to 2050 1 to 852       852/896
(95 %)
24 diff
(97.4 %id)
BE796174 lung, small cell carcinoma .c 1195 to 2054 1 to 863       863/950
(90 %)
23 diff
(97.6 %id)
BE408494 choriocarcinoma, placenta .c 1214 to 1897 1 to 681       681/734
(92 %)
6 diff
(99.2 %id)
BU191829 embryonal carcinoma, cell line, testis .c 1221 to 1508 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BM853078 Ascites, stomach .c 1221 to 1677 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
DA731879   .c 1229 to 1830 2 to 603   capped   602/607
(99 %)
6 diff
(99.1 %id)
BG770432 melanotic melanoma, high MDR (cell line), skin .c 1246 to 1894 1 to 649       649/653
(99 %)
3 diff
(99.6 %id)
AA078186   .c 1250 to 1516 1 to 268       268/273
(98 %)
3 diff
(99.0 %id)
R90838 brain .c 1253 to 1458 206 to 1       206/206
(100 %)
0 diff
(100 %id)
DB059360 testis .c 1273 to 1815 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DN989444 brain, whole brain .c 1274 to 1886 1 to 613       613/613
(100 %)
5 diff
(99.2 %id)
BP330267 rectum .c 1281 to 1680 1 to 400       400/581
(68 %)
8 diff
(98.7 %id)
BQ052290 blood, natural killer cells, cell line .c 1286 to 2245 21 to 980       960/1065
(90 %)
32 diff
(97.0 %id)
DB034339 testis .c 1286 to 1837 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
CB268946 adipose .c 1287 to 1963 1 to 670       672/670
(100 %)
12 diff
(98.3 %id)
DB447397 testis .c 1295 to 1492 1 to 198       198/198
(100 %)
1 diff
(99.5 %id)
BU849579 ovary, teratocarcinoma, cell line .c 1304 to 2178 1 to 883       883/900
(98 %)
16 diff
(98.3 %id)
AI738936 colon, colon tumor, RER+ .c 1328 to 1498 171 to 1       171/171
(100 %)
8 diff
(95.4 %id)
TI_151770380   .c 1416 to 2245 107 to 931       825/871
(94 %)
20 diff
(97.8 %id)
DA611314   .d 1 to 464 2 to 466   tiling clone, capped   465/467
(99 %)
2 diff
(99.6 %id)
NM_001128854.1   .d 1 to 2998 1 to 2999 exact RefSeq, AAA   2999/2999
(100 %)
1 diff
(100.0 %id)
DB085186 testis .d 2 to 560 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
TI_154197445   .d 8 to 741 59 to 782       727/1008
(72 %)
27 diff
(97.4 %id)
TI_154195813   .d 16 to 856 1 to 836       836/1041
(80 %)
35 diff
(96.7 %id)
DB454177 testis .d 26 to 507 1 to 483       483/483
(100 %)
2 diff
(99.6 %id)
DB473409 hippocampus .d 26 to 583 1 to 560       560/560
(100 %)
2 diff
(99.7 %id)
DA648594   .d 28 to 570 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BG685713 B-cells, primary B-cells from tonsils (cell line) .d 34 to 762 1 to 726       726/726
(100 %)
7 diff
(99.1 %id)
DA909233   .d 34 to 611 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
BE297447 muscle, rhabdomyosarcoma .d 45 to 632 31 to 619       589/619
(95 %)
10 diff
(98.4 %id)
CN421981 embryonic stem cells, cell lines H1, H7, andH9 .d 46 to 569 1 to 525       525/525
(100 %)
3 diff
(99.5 %id)
BM560619 astrocytoma grade IV, cell line, brain .d 51 to 581 1 to 533       533/537
(99 %)
7 diff
(98.7 %id)
DA576642   .d 54 to 578 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
BE299118 muscle, rhabdomyosarcoma .d 72 to 840 1 to 777       777/809
(96 %)
10 diff
(98.8 %id)
CN421983 embryonic stem cells, cell lines H1, H7, andH9 .d 73 to 404 1 to 333       333/333
(100 %)
1 diff
(99.7 %id)
BE796844 lung, small cell carcinoma .d 73 to 856 1 to 776       776/966
(80 %)
17 diff
(98.3 %id)
CN421969 embryonic stem cells, cell lines H1, H7, andH9 .d 83 to 577 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
CF125729 Chondrosarcoma Lung Metastasis cell lines, lung .d 88 to 807 1 to 721       721/721
(100 %)
6 diff
(99.2 %id)
TI_154186570   .d 88 to 828 23 to 764       742/742
(100 %)
6 diff
(99.2 %id)
CN421973 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 102 to 565 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
CN421977 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 105 to 578 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
BM552580 astrocytoma grade IV, cell line, brain .d 106 to 855 1 to 757       757/1023
(73 %)
42 diff
(95.9 %id)
BC109117 PCR rescued clones .d 107 to 2998 1 to 2893 exact tiling clone,   2893/2894
(99 %)
2 diff
(100.0 %id)
BP210074 cerebellum .d 110 to 689 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BE267206 lung, small cell carcinoma .d 112 to 848 1 to 734       734/741
(99 %)
25 diff
(96.7 %id)
CN421972 embryonic stem cells, cell lines H1, H7, andH9 .d 114 to 581 1 to 469       469/469
(100 %)
2 diff
(99.6 %id)
BG421801 Kidney, renal cell adenocarcinoma .d 115 to 744 1 to 633       633/633
(100 %)
8 diff
(98.8 %id)
CN421984 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 116 to 568 1 to 454       454/454
(100 %)
3 diff
(99.4 %id)
BG386813 adenocarcinoma cell line, colon .d 123 to 897 1 to 770       770/869
(88 %)
31 diff
(96.5 %id)
DA795172 brain .d 127 to 596 2 to 474   capped   473/473
(100 %)
4 diff
(99.2 %id)
DN998887 bone marrow .d 127 to 843 1 to 719       719/719
(100 %)
8 diff
(98.9 %id)
CN421975 embryonic stem cells, cell lines H1, H7, andH9 .d 128 to 568 1 to 442       442/442
(100 %)
4 diff
(99.1 %id)
BI225665 Burkitt lymphoma, lymph .d 135 to 483 1 to 351       351/351
(100 %)
3 diff
(99.2 %id)
CN421974 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 139 to 578 1 to 441       441/441
(100 %)
2 diff
(99.6 %id)
CF124984 Chondrosarcoma Lung Metastasis cell lines, lung .d 154 to 840 1 to 688       688/688
(100 %)
2 diff
(99.8 %id)
TI_154186362   .d 154 to 900 49 to 795       747/747
(100 %)
6 diff
(99.2 %id)
BE559754 Burkitt lymphoma, lymph .d 161 to 908 1 to 744       744/744
(100 %)
25 diff
(96.7 %id)
AI142109 pooled .d 236 to 718 1 to 483     Submitted on the opposite strand 483/483
(100 %)
2 diff
(99.6 %id)
AI480057 anaplastic oligodendroglioma, brain .d 236 to 701 1 to 466     Submitted on the opposite strand 466/466
(100 %)
4 diff
(99.2 %id)
AW183066 pooled .d 236 to 581 1 to 346     Submitted on the opposite strand 346/346
(100 %)
1 diff
(99.8 %id)
BE219415 carcinoid, lung .d 236 to 579 1 to 344     Submitted on the opposite strand 344/344
(100 %)
0 diff
(100 %id)
BF115306 fibrotheoma, ovary .d 236 to 578 1 to 343     Submitted on the opposite strand 343/347
(98 %)
2 diff
(99.5 %id)
AW450315   .d 237 to 581 1 to 345     Submitted on the opposite strand 345/345
(100 %)
0 diff
(100 %id)
BF512586   .d 237 to 753 1 to 517     Submitted on the opposite strand 517/517
(100 %)
2 diff
(99.7 %id)
CD358621 testis .d 241 to 582 1 to 343       343/344
(99 %)
5 diff
(98.6 %id)
AW005928 anaplastic oligodendroglioma, brain .d 245 to 583 1 to 340     Submitted on the opposite strand 340/340
(100 %)
3 diff
(99.2 %id)
BQ437140 melanotic melanoma, skin .d 245 to 856 610 to 1     Submitted on the opposite strand 610/611
(99 %)
5 diff
(99.2 %id)
AI972631 Prostate .d 261 to 854 1 to 594     Submitted on the opposite strand 594/594
(100 %)
3 diff
(99.5 %id)
AA236853 germinal center B cell .d 278 to 719 1 to 441     Submitted on the opposite strand 441/441
(100 %)
2 diff
(99.6 %id)
AI475785 B-cell, chronic lymphotic leukemia .d 278 to 692 1 to 415     Submitted on the opposite strand 415/415
(100 %)
0 diff
(100 %id)
AI818149 anaplastic oligodendroglioma, brain .d 287 to 801 1 to 517     Submitted on the opposite strand 517/517
(100 %)
5 diff
(99.1 %id)
CV574318 cornea, eye .d 301 to 870 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
CX755964 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 302 to 581 1 to 280     Submitted on the opposite strand 280/280
(100 %)
0 diff
(100 %id)
AA832291 germinal center B cell .d 303 to 738 1 to 434     Submitted on the opposite strand 434/434
(100 %)
4 diff
(99.1 %id)
CN421968 embryonic stem cells, cell lines H1, H7, andH9 .d 381 to 613 1 to 234       234/234
(100 %)
2 diff
(99.2 %id)
BM020230 astrocytoma grade IV, cell line, brain .d 458 to 1124 1 to 673       673/679
(99 %)
20 diff
(97.1 %id)
BM020130 astrocytoma grade IV, cell line, brain .d 458 to 1087 1 to 636       636/681
(93 %)
15 diff
(97.8 %id)
TI_59388672   .d 459 to 1087 147 to 780       634/635
(99 %)
19 diff
(97.1 %id)
TI_59390910   .d 459 to 1087 109 to 743   AAA   635/670
(94 %)
14 diff
(98.0 %id)
TI_59391011   .d 459 to 1124 112 to 783       672/678
(99 %)
19 diff
(97.2 %id)
TI_59391238   .d 459 to 1063 107 to 716       610/690
(88 %)
16 diff
(97.7 %id)
BE512744 adenocarcinoma cell line, colon .d 462 to 1184 1 to 726       726/861
(84 %)
12 diff
(98.7 %id)
BE794090 lung, small cell carcinoma .d 542 to 1090 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
BG477711 melanotic melanoma, skin .d 617 to 1308 1 to 703       703/1141
(61 %)
21 diff
(98.2 %id)
BE275426 melanotic melanoma, skin .d 637 to 1305 1 to 674       672/700
(96 %)
24 diff
(96.6 %id)
CN421971 embryonic stem cells, DMSO-treated H9 cellline .d 646 to 986 1 to 341       341/341
(100 %)
0 diff
(100 %id)
CB177465 Pancreas, Purified pancreatic islet .d 793 to 949 1 to 157   fully sequenced,   157/157
(100 %)
5 diff
(96.9 %id)
BF311798 brain, neuroblastoma .d 808 to 1476 1 to 665       665/898
(74 %)
11 diff
(98.8 %id)
BE312698 brain, neuroblastoma .d 829 to 1122 1 to 294       294/294
(100 %)
1 diff
(99.7 %id)
BF819564 kidney_tumor .d 847 to 1410 1 to 561       561/564
(99 %)
12 diff
(97.9 %id)
BE174786 head_neck .d 870 to 1263 424 to 32     Submitted on the opposite strand 393/448
(87 %)
6 diff
(98.7 %id)
BE646076 B-cell, chronic lymphotic leukemia .d 874 to 1458 585 to 1       585/585
(100 %)
1 diff
(99.9 %id)
W73668 heart .d 905 to 1284 397 to 15   AAA Submitted on the opposite strand 383/398
(96 %)
5 diff
(98.8 %id)
CB177846 Pancreas, Purified pancreatic islet .d 919 to 1478 560 to 1   fully sequenced,   560/560
(100 %)
1 diff
(99.9 %id)
BE791341 lung, small cell carcinoma .d 924 to 1263 1 to 338       338/338
(100 %)
3 diff
(99.2 %id)
BI792333 Pancreas, Purified pancreatic islet .d 925 to 1513 590 to 2       589/590
(99 %)
0 diff
(100 %id)
AW770857 colon, juvenile granulosa tumor .d 928 to 1514 587 to 1       587/587
(100 %)
0 diff
(100 %id)
DA463209   .d 969 to 1514 2 to 547   capped   546/546
(100 %)
3 diff
(99.5 %id)
AA077908   .d 978 to 1176 199 to 1       199/199
(100 %)
1 diff
(99.5 %id)
DA481809   .d 1004 to 1532 2 to 531   capped   530/530
(100 %)
3 diff
(99.5 %id)
DA649323   .d 1030 to 1567 2 to 541   capped   540/541
(99 %)
5 diff
(99.1 %id)
DA377717 thalamus .d 1032 to 1605 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BM834767 stomach .d 1033 to 1312 1 to 280       280/280
(100 %)
0 diff
(100 %id)
AI540071 B-cell, chronic lymphotic leukemia .d 1051 to 1458 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
BG768701 melanotic melanoma, high MDR (cell line), skin .d 1178 to 1911 1 to 739       739/798
(92 %)
18 diff
(97.8 %id)
CD627309   .d 1193 to 1868 15 to 689       675/689
(97 %)
16 diff
(97.7 %id)
CD627311   .d 1193 to 1755 11 to 573       563/573
(98 %)
6 diff
(99.0 %id)
BF684562 leiomyosarcoma cell line, uterus .d 1210 to 2036 1 to 823       823/894
(92 %)
31 diff
(96.6 %id)
BP265481 thyroid .d 1238 to 1818 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BG822240 adenocarcinoma cell line, colon .d 1262 to 1969 1 to 714       714/715
(99 %)
14 diff
(98.1 %id)
BQ069870 brain, neuroblastoma, cell line .d 1262 to 2157 1 to 918       918/926
(99 %)
16 diff
(98.3 %id)
DA832552 placenta .d 1272 to 2019 2 to 755   capped   754/757
(99 %)
25 diff
(96.7 %id)
BP332337 renal proximal tubule .d 1318 to 1897 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AI917211 pooled germ cell tumors .d 1322 to 1458 137 to 1       137/137
(100 %)
0 diff
(100 %id)
AI654926 pooled germ cell tumors .d 1322 to 1458 137 to 1       137/137
(100 %)
0 diff
(100 %id)
AW236623 pooled germ cell tumors .d 1322 to 1458 137 to 1       137/137
(100 %)
0 diff
(100 %id)
BE388703 endometrium, adenocarcinoma cell line, uterus .d 1334 to 2024 1 to 687       689/689
(100 %)
11 diff
(98.5 %id)
BM916286 amelanotic melanoma, cell line, skin .d 1355 to 2087 12 to 747       736/1088
(67 %)
16 diff
(98.6 %id)
TI_59385122   .d 1355 to 2043 95 to 786       692/692
(100 %)
4 diff
(99.5 %id)
BM010314 amelanotic melanoma, cell line, skin .d 1360 to 2043 1 to 687       687/687
(100 %)
4 diff
(99.5 %id)
BM553083 amelanotic melanoma, cell line, skin .d 1361 to 2337 1 to 986       984/1102
(89 %)
14 diff
(98.8 %id)
BM561086 amelanotic melanoma, cell line, skin .d 1361 to 2193 1 to 836       836/1090
(76 %)
12 diff
(98.9 %id)
BG476334 melanotic melanoma, skin .d 1408 to 2239 1 to 835       835/854
(97 %)
21 diff
(97.6 %id)
AW963788   .d 1459 to 2077 1 to 622       622/622
(100 %)
14 diff
(97.8 %id)
BG745359 Spleen .d 1474 to 2086 1 to 613       613/782
(78 %)
15 diff
(98.1 %id)
BM008371 Spleen .d 1474 to 2041 1 to 569       569/572
(99 %)
4 diff
(99.4 %id)
BE792722 lung, small cell carcinoma .d 1479 to 2138 1 to 659       659/659
(100 %)
1 diff
(99.9 %id)
BE257581 eye, retinoblastoma .d 1485 to 2073 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BE256358 eye, retinoblastoma .d 1486 to 2040 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
BE273191 Kidney, renal cell adenocarcinoma .d 1495 to 2187 1 to 684   available from MGC,   684/726
(94 %)
14 diff
(98.1 %id)
DA142693 alzheimer cortex .d 1498 to 2028 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
CD627312   .d 1504 to 2209 743 to 32       712/745
(95 %)
19 diff
(97.5 %id)
BF111848 pooled .d 1504 to 1916 1 to 414     Submitted on the opposite strand 414/414
(100 %)
4 diff
(99.1 %id)
AI745140 ovary, tumor, 5 pooled (see description) .d 1505 to 1993 1 to 489     Submitted on the opposite strand 489/489
(100 %)
1 diff
(99.8 %id)
AI478326 Kidney .d 1506 to 1900 1 to 395     Submitted on the opposite strand 395/395
(100 %)
0 diff
(100 %id)
AI700243 colon .d 1506 to 1954 1 to 449     Submitted on the opposite strand 449/449
(100 %)
2 diff
(99.6 %id)
AI951524 fibrotheoma, ovary .d 1506 to 2239 1 to 730     Submitted on the opposite strand 730/735
(99 %)
21 diff
(97.2 %id)
BF446308 Prostate .d 1506 to 1999 1 to 494     Submitted on the opposite strand 494/494
(100 %)
0 diff
(100 %id)
AA910848 Kidney .d 1507 to 2002 1 to 495     Submitted on the opposite strand 495/498
(99 %)
4 diff
(99.2 %id)
AW291495   .d 1507 to 2021 1 to 514     Submitted on the opposite strand 514/514
(100 %)
1 diff
(99.9 %id)
AI634836 Kidney .d 1512 to 1901 1 to 391     Submitted on the opposite strand 391/391
(100 %)
1 diff
(99.8 %id)
AW301115 colon, moderately differentiated adenocarcinoma .d 1512 to 2145 1 to 634     Submitted on the opposite strand 634/634
(100 %)
1 diff
(99.9 %id)
BF940704 fibrotheoma, ovary .d 1516 to 1992 1 to 476     Submitted on the opposite strand 476/476
(100 %)
1 diff
(99.8 %id)
BF900431 marrow .d 1524 to 1936 1 to 412       412/412
(100 %)
4 diff
(99.1 %id)
AI130771 heart .d 1524 to 1906 1 to 383     Submitted on the opposite strand 383/383
(100 %)
0 diff
(100 %id)
AI885373 anaplastic oligodendroglioma, brain .d 1524 to 2000 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
TI_154185455   .d 1539 to 2323 114 to 886       773/994
(77 %)
37 diff
(96.3 %id)
BQ777580 Pancreas, Purified pancreatic islet .d 1542 to 2148 1 to 607     Submitted on the opposite strand 607/607
(100 %)
0 diff
(100 %id)
AA760735 germinal center B cell .d 1571 to 1894 1 to 324     Submitted on the opposite strand 324/324
(100 %)
0 diff
(100 %id)
AF082871   .d 1589 to 2998 1 to 1410   AAA   1410/1410
(100 %)
0 diff
(100 %id)
N30352 placenta .d 1589 to 1996 1 to 407     Submitted on the opposite strand 407/407
(100 %)
3 diff
(99.3 %id)
AA455631 germinal center B cell .d 1589 to 1975 1 to 387     Submitted on the opposite strand 387/387
(100 %)
2 diff
(99.5 %id)
AA837257 germinal center B cell .d 1589 to 1981 1 to 391       391/391
(100 %)
3 diff
(99.3 %id)
AA969303 pooled .d 1589 to 1928 1 to 339     Submitted on the opposite strand 339/339
(100 %)
1 diff
(99.8 %id)
AI083601 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1589 to 1906 1 to 317     Submitted on the opposite strand 317/317
(100 %)
1 diff
(99.7 %id)
BQ940732 brain, neuroblastoma, cell line .d 1597 to 2434 1 to 841       841/857
(98 %)
13 diff
(98.5 %id)
BG676065 skin, squamous cell carcinoma .d 1598 to 2299 1 to 715       715/716
(99 %)
23 diff
(96.8 %id)
BE560916 Burkitt lymphoma, lymph .d 1621 to 2393 764 to 1     Submitted on the opposite strand 764/766
(99 %)
15 diff
(98.1 %id)
BI224888 Burkitt lymphoma, lymph .d 1645 to 2414 769 to 1     Submitted on the opposite strand 769/772
(99 %)
7 diff
(99.1 %id)
BE869283 adenocarcinoma, colon .d 1651 to 2356 1 to 706       706/933
(75 %)
19 diff
(98.0 %id)
BE562040 Burkitt lymphoma, lymph .d 1665 to 2422 798 to 49     Submitted on the opposite strand 750/848
(88 %)
10 diff
(98.9 %id)
BM474513 leiomyosarcoma, uterus .d 1666 to 2590 1 to 933       933/1013
(92 %)
19 diff
(98.2 %id)
CX763280 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1681 to 2471 1 to 784     Submitted on the opposite strand 786/789
(99 %)
19 diff
(97.6 %id)
CB138703 Liver .d 1683 to 2183 1 to 502       502/503
(99 %)
3 diff
(99.5 %id)
BG577104 breast, mammary adenocarcinoma, cell line .d 1691 to 2437 1 to 751       751/823
(91 %)
23 diff
(97.3 %id)
AA044012 uterus .d 1699 to 2002 1 to 304       304/306
(99 %)
4 diff
(98.7 %id)
AA077071 brain .d 1700 to 1989 1 to 290       290/290
(100 %)
2 diff
(99.4 %id)
AW801811 uterus .d 1708 to 2082 375 to 1       375/375
(100 %)
1 diff
(99.8 %id)
BM745474 Ascites, stomach .d 1708 to 2286 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BQ059529 lymph, lymphoma, cell line .d 1710 to 2594 10 to 902       893/1048
(85 %)
40 diff
(96.2 %id)
BQ645819 hepatocellular carcinoma, cell line, Liver .d 1719 to 2547 25 to 870       846/927
(91 %)
32 diff
(96.6 %id)
BQ647022 hepatocellular carcinoma, cell line, Liver .d 1719 to 2590 13 to 892       880/938
(93 %)
23 diff
(97.6 %id)
BQ648960 hepatocellular carcinoma, cell line, Liver .d 1719 to 2678 11 to 993       981/1014
(96 %)
45 diff
(95.6 %id)
BF915561 uterus_tumor .d 1730 to 2264 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BG250288 adenocarcinoma, cell line, Liver .d 1742 to 2436 1 to 690       690/916
(75 %)
12 diff
(98.7 %id)
CN425882 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1749 to 2208 1 to 460       460/460
(100 %)
4 diff
(99.2 %id)
BE397196 Burkitt lymphoma, lymph .d 1750 to 2396 646 to 1     Submitted on the opposite strand 646/650
(99 %)
1 diff
(99.9 %id)
BX111454 breast .d 1758 to 2522 1 to 766       766/766
(100 %)
1 diff
(99.9 %id)
BE514242 Burkitt lymphoma, lymph .d 1762 to 2431 691 to 25     Submitted on the opposite strand 667/691
(96 %)
2 diff
(99.8 %id)
BI226558 Burkitt lymphoma, lymph .d 1766 to 2413 648 to 1     Submitted on the opposite strand 648/648
(100 %)
2 diff
(99.7 %id)
BE397571 Burkitt lymphoma, lymph .d 1776 to 2399 636 to 15     Submitted on the opposite strand 622/639
(97 %)
1 diff
(99.9 %id)
CB111742 Liver .d 1788 to 2306 1 to 517       517/517
(100 %)
2 diff
(99.7 %id)
CB158279 Liver .d 1807 to 2070 1 to 264       264/264
(100 %)
0 diff
(100 %id)
BM824367 Ascites, stomach .d 1820 to 2237 1 to 418       418/418
(100 %)
1 diff
(99.8 %id)
BE734514 choriocarcinoma, placenta .d 1832 to 2616 34 to 812       779/815
(95 %)
15 diff
(98.2 %id)
AI908297 breast .d 1847 to 2494 662 to 13       650/662
(98 %)
6 diff
(99.1 %id)
BG755566 B-cells, primary B-cells from tonsils (cell line) .d 1848 to 2518 1 to 671       671/672
(99 %)
4 diff
(99.5 %id)
BG741756 skin .d 1863 to 2543 1 to 680       680/680
(100 %)
2 diff
(99.8 %id)
BE902590 choriocarcinoma, placenta .d 1866 to 2596 1 to 730       730/1186
(61 %)
13 diff
(99.0 %id)
AA076821 brain .d 2030 to 2207 1 to 178       178/178
(100 %)
1 diff
(99.5 %id)
AA077828   .d 2065 to 2257 194 to 1       194/194
(100 %)
1 diff
(99.5 %id)
BM791957 Ascites, stomach .d 2066 to 2552 1 to 487       487/487
(100 %)
2 diff
(99.6 %id)
BG746178 Spleen .d 2084 to 2950 883 to 1       881/963
(91 %)
42 diff
(95.7 %id)
AA455684 germinal center B cell .d 2106 to 2539 431 to 1     Submitted on the opposite strand 431/431
(100 %)
4 diff
(99.1 %id)
AA371977 pituitary gland .d 2137 to 2371 1 to 235       235/235
(100 %)
0 diff
(100 %id)
CR615585 Neuroblastoma Cot 25-normalized .d 2160 to 2998 1 to 839       839/839
(100 %)
0 diff
(100 %id)
AL527779 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 2160 to 2998 1 to 839   fully sequenced,   839/839
(100 %)
0 diff
(100 %id)
CB050393 Prostate .d 2172 to 2391 2 to 221       220/224
(98 %)
13 diff
(94.2 %id)
AA077010 brain .d 2192 to 2358 166 to 1       166/166
(100 %)
1 diff
(99.4 %id)
CX163628 human embryonic stem cells differentiated toan early endodermal cell type .d 2221 to 2998 808 to 31   AAA Submitted on the opposite strand 778/778
(100 %)
2 diff
(99.8 %id)
AA361486   .d 2226 to 2482 1 to 257       257/257
(100 %)
0 diff
(100 %id)
BM792788 Ascites, stomach .d 2235 to 2766 1 to 532       532/532
(100 %)
0 diff
(100 %id)
BM840646 lymph node, stomach .d 2241 to 2709 1 to 469       469/469
(100 %)
0 diff
(100 %id)
BU633704 cell lines, Chondrosarcoma .d 2263 to 2998 752 to 19   AAA   734/734
(100 %)
3 diff
(99.6 %id)
BG756070 B-cells, primary B-cells from tonsils (cell line) .d 2270 to 2998 1 to 728       728/920
(79 %)
4 diff
(99.6 %id)
DB542187 hippocampus .d 2338 to 2998 1 to 661     Submitted on the opposite strand 661/661
(100 %)
6 diff
(99.1 %id)
CX760899 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 2395 to 2998 1 to 604     Submitted on the opposite strand 604/611
(98 %)
1 diff
(99.9 %id)
BU733881 eye, Retina Foveal and Macular .d 2411 to 2998 606 to 19   AAA   588/588
(100 %)
0 diff
(100 %id)
AA077061 brain .d 2423 to 2570 1 to 148       148/148
(100 %)
1 diff
(99.4 %id)
BU164727 eye, retinoblastoma .d 2431 to 2998 8 to 576       569/580
(98 %)
2 diff
(99.7 %id)
TI_157609522   .d 2441 to 2998 652 to 95   AAA   558/559
(99 %)
1 diff
(99.9 %id)
BG231968 blood, lymphocyte .d 2443 to 2998 561 to 6       556/561
(99 %)
0 diff
(100 %id)
AI201787 anaplastic oligodendroglioma, brain .d 2503 to 2998 500 to 5       496/500
(99 %)
2 diff
(99.6 %id)
AA483291 colon .d 2512 to 2998 495 to 11   AAA   485/485
(100 %)
6 diff
(98.8 %id)
AI184210 placenta .d 2513 to 2998 490 to 4       487/490
(99 %)
2 diff
(99.6 %id)
AI144312 B-cell, chronic lymphotic leukemia .d 2544 to 2998 465 to 11   AAA   455/455
(100 %)
2 diff
(99.6 %id)
DB523940 testis .d 2545 to 2998 1 to 453     Submitted on the opposite strand 453/453
(100 %)
1 diff
(99.8 %id)
CB050392 Prostate .d 2614 to 2998 421 to 37   AAA   385/385
(100 %)
1 diff
(99.8 %id)
AA043976 uterus .d 2641 to 2998 377 to 15   AAA   361/367
(98 %)
4 diff
(99.0 %id)
AL527778 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 2650 to 2961 316 to 6   fully sequenced,   311/316
(98 %)
0 diff
(100 %id)
BE675611 B-cell, chronic lymphotic leukemia .d 2680 to 2806 127 to 1       127/127
(100 %)
0 diff
(100 %id)
DB115848 thymus .e 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
BM974251 lung .e 103 to 224 18 to 139     Submitted on the opposite strand 122/139
(87 %)
6 diff
(95.7 %id)
CX754885 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 530 to 1206 712 to 36   tiling clone, AAA Submitted on the opposite strand 677/713
(94 %)
2 diff
(99.8 %id)
BM791859 Ascites, stomach .e 566 to 1157 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
BU732573 eye, optic nerve .e 621 to 1206 604 to 19   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 586/604
(97 %)
0 diff
(100 %id)
R87621 brain .e 755 to 1193 452 to 10     Submitted on the opposite strand 443/452
(98 %)
12 diff
(97.4 %id)
TI_57176659   .f 1 to 468 64 to 533   tiling clone,   470/714
(65 %)
10 diff
(98.6 %id)
BI829974 brain, medulla .f 5 to 468 1 to 465       465/646
(71 %)
3 diff
(99.6 %id)
DB461574 testis .f 9 to 450 1 to 442       442/448
(98 %)
1 diff
(99.8 %id)
BI826909 brain, medulla .f 13 to 712 1 to 703   tiling clone,   703/703
(100 %)
4 diff
(99.5 %id)
TI_57174321   .f 13 to 712 91 to 793       703/793
(88 %)
8 diff
(99.0 %id)
DB458440 testis .f 18 to 500 1 to 483       483/483
(100 %)
2 diff
(99.6 %id)
BI829947 brain, medulla .f 119 to 881 1 to 757   tiling clone,   757/757
(100 %)
19 diff
(97.5 %id)
TI_57176547   .f 119 to 881 28 to 784       757/784
(96 %)
25 diff
(96.9 %id)
CT002166 T-Lymphocytes .f 580 to 1352 99 to 869   tiling clone,   771/872
(88 %)
6 diff
(99.4 %id)
CV574992 cornea, eye .f 808 to 1455 1 to 648       648/648
(100 %)
0 diff
(100 %id)
AA053848 eye, retina .f 1098 to 1635 1 to 529       529/570
(92 %)
11 diff
(98.1 %id)
AI239482 pooled .f 1121 to 1529 1 to 408     Submitted on the opposite strand 408/408
(100 %)
1 diff
(99.8 %id)
AI333756 lung .f 1121 to 1568 1 to 447   tiling clone, Submitted on the opposite strand 447/447
(100 %)
3 diff
(99.4 %id)
CF136785 lymph .f 1320 to 1568 8 to 256       249/256
(97 %)
6 diff
(97.7 %id)
TI_154166023   .f 1320 to 1816 81 to 577       497/498
(99 %)
36 diff
(92.8 %id)
BF089563 head_neck .f 1372 to 1728 35 to 390   tiling clone,   356/390
(91 %)
6 diff
(98.5 %id)
BE093141 breast .f 1572 to 1933 4 to 365       362/365
(99 %)
6 diff
(98.4 %id)
BI018525 marrow .f 1615 to 1978 6 to 371       366/372
(98 %)
6 diff
(98.4 %id)
CN370751 embryonic stem cells, cell lines H1, H7, andH9 .f 1628 to 2100 1 to 474   tiling clone,   474/474
(100 %)
3 diff
(99.4 %id)
CN370752 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 1827 to 2442 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
BQ776429 Pancreas, Purified pancreatic islet .f 1847 to 2453 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
BQ081880 stomach .f 1879 to 2369 1 to 491       491/491
(100 %)
4 diff
(99.2 %id)
BQ082050 stomach .f 1879 to 2077 1 to 199       199/199
(100 %)
2 diff
(99.0 %id)
CX873005 embryonic stem .f 1897 to 2619 1 to 723   tiling clone,   723/723
(100 %)
0 diff
(100 %id)
H91729 eye, retina .f 1919 to 2296 1 to 388       388/404
(96 %)
19 diff
(95.3 %id)
CV316590 uterus_tumor .f 2013 to 2449 10 to 444       435/444
(97 %)
10 diff
(97.8 %id)
BM888198 eye .f 2121 to 2318 1 to 200       200/200
(100 %)
14 diff
(93.0 %id)
BF813306 colon_ins .f 2188 to 2602 10 to 428       419/428
(97 %)
6 diff
(98.6 %id)
AA077324 brain .f 2456 to 2751 1 to 295       295/295
(100 %)
5 diff
(98.4 %id)
G30916   .f 2456 to 2751 1 to 295       295/295
(100 %)
5 diff
(98.4 %id)
BF993962 placenta_normal .f 2460 to 2811 23 to 373       351/373
(94 %)
6 diff
(98.4 %id)
BF843670 head_neck .f 2524 to 2665 141 to 1     Submitted on the opposite strand 141/203
(69 %)
3 diff
(98.6 %id)
BQ778516 Pancreas, Purified pancreatic islet .f 2592 to 3175 584 to 1   tiling clone,   584/584
(100 %)
0 diff
(100 %id)
AA076815 brain .g 1 to 313 313 to 1   tiling clone,   313/313
(100 %)
1 diff
(99.7 %id)
BX479814   .g 245 to 655 1 to 414   tiling clone,   414/414
(100 %)
5 diff
(98.8 %id)
BQ345825 nervous_tumor .h 1 to 376 1 to 377   tiling clone,   377/377
(100 %)
2 diff
(99.5 %id)
BM723086 eye, fetal eye .h 228 to 747 1 to 520   tiling clone, fully sequenced,   520/520
(100 %)
0 diff
(100 %id)
AK292467 testis .h 667 to 2227 1561 to 1   tiling clone, Submitted on the opposite strand 1561/1561
(100 %)
2 diff
(99.9 %id)
BF881831 lung_tumor .h 700 to 1160 1 to 461       461/461
(100 %)
1 diff
(99.8 %id)
BM677618 eye, fetal eye .h 717 to 1173 475 to 19   tiling clone, fully sequenced, AAA   457/457
(100 %)
2 diff
(99.6 %id)
AW166438 cervix .h 745 to 1173 434 to 7       428/438
(97 %)
0 diff
(100 %id)
AI523895 B-cell, chronic lymphotic leukemia .h 753 to 1173 436 to 16   AAA   421/421
(100 %)
2 diff
(99.6 %id)
AA505539 breast .h 784 to 1172 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
AA830626 germinal center B cell .h 904 to 1172 314 to 48   AAA   267/267
(100 %)
3 diff
(98.9 %id)
BE830637 marrow .h 1129 to 1288 1 to 159       159/164
(96 %)
6 diff
(96.4 %id)
AW089648 ovary, tumor, 5 pooled (see description) .h 1227 to 1430 1 to 204     Submitted on the opposite strand 204/204
(100 %)
4 diff
(98.1 %id)
BC017456 Skin, melanotic melanoma. .h 1232 to 2162 931 to 1   tiling clone, available from MGC, Submitted on the opposite strand 931/951
(97 %)
0 diff
(100 %id)
BQ012197 placenta .h 1232 to 1642 14 to 424     Submitted on the opposite strand 411/424
(96 %)
7 diff
(98.4 %id)
BC067904 Brain, hypothalamus .h 1234 to 2190 957 to 1   available from MGC, Submitted on the opposite strand 957/974
(98 %)
2 diff
(99.8 %id)
BX281619 brain, hypothalamus .h 1234 to 1655 30 to 451       422/451
(93 %)
6 diff
(98.7 %id)
AI361150 brain, glioblastoma (pooled) .h 1234 to 1635 1 to 402     Submitted on the opposite strand 402/402
(100 %)
1 diff
(99.8 %id)
AI939490 brain, glioblastoma (pooled) .h 1234 to 1444 1 to 211     Submitted on the opposite strand 211/211
(100 %)
0 diff
(100 %id)
BF438568 brain, glioblastoma (pooled) .h 1234 to 1786 1 to 554     Submitted on the opposite strand 554/556
(99 %)
43 diff
(92.3 %id)
BI666650 brain, hypothalamus .h 1302 to 2191 891 to 5     Submitted on the opposite strand 887/897
(98 %)
0 diff
(100 %id)
TI_44342675   .h 1302 to 2199 971 to 77     Submitted on the opposite strand 895/977
(91 %)
20 diff
(98.0 %id)
BE891729 melanotic melanoma, skin .h 1497 to 2153 659 to 1   available from MGC, Submitted on the opposite strand 659/659
(100 %)
7 diff
(99.0 %id)
CN359690 embryonic stem cells, cell lines H1, H7, andH9 .h 1632 to 2181 549 to 1     Submitted on the opposite strand 549/549
(100 %)
1 diff
(99.9 %id)
H80808 eye, retina .i 1 to 258 1 to 259       259/259
(100 %)
2 diff
(99.3 %id)
H85928 eye, retina .i 1 to 207 1 to 207       207/209
(99 %)
1 diff
(99.6 %id)
R93864 eye, retina .i 1 to 343 1 to 349       349/360
(96 %)
9 diff
(97.5 %id)
AA017619 eye, retina .i 1 to 166 1 to 167       167/167
(100 %)
1 diff
(99.5 %id)
AA021126 eye, retina .i 1 to 433 1 to 434   tiling clone,   434/434
(100 %)
8 diff
(98.2 %id)
AW968501   .i 108 to 613 15 to 522       508/522
(97 %)
11 diff
(97.9 %id)
AA252479 germinal center B cell .i 108 to 514 28 to 423       396/427
(92 %)
8 diff
(98.2 %id)
BI715128 Pancreas, Purified pancreatic islet .i 219 to 834 1 to 616   tiling clone,   616/621
(99 %)
5 diff
(99.2 %id)
AA017525 eye, retina .i 643 to 1082 445 to 1   tiling clone,   445/454
(98 %)
11 diff
(97.6 %id)
AA021127 eye, retina .i 721 to 1098 380 to 1   tiling clone,   380/380
(100 %)
4 diff
(99.0 %id)
R93822 eye, retina .i 725 to 1078 355 to 1       355/356
(99 %)
6 diff
(98.4 %id)
H80809 eye, retina .i 792 to 1090 300 to 1       300/301
(99 %)
2 diff
(99.4 %id)
H85856 eye, retina .i 933 to 1082 150 to 1       150/150
(100 %)
0 diff
(100 %id)
BP355798   .j 1 to 579 1 to 582 A34V A70G A71R A72G A73R ... tiling clone,   582/582
(100 %)
6 diff
(99.0 %id)
BF871681 lung_tumor .j 362 to 674 15 to 327   tiling clone,   313/334
(93 %)
14 diff
(95.9 %id)
BF841697 head_neck .j 483 to 592 125 to 16     Submitted on the opposite strand 110/125
(88 %)
0 diff
(100 %id)
CN421967 embryonic stem cells, cell lines H1, H7, andH9 .k 1 to 557 1 to 558 S14G A51G A52R A53G A54R ... tiling clone,   558/558
(100 %)
5 diff
(99.2 %id)
CN421987 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 8 to 570 1 to 563   tiling clone,   563/563
(100 %)
2 diff
(99.7 %id)
CN421970 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 36 to 570 1 to 535       535/536
(99 %)
4 diff
(99.3 %id)
BE247268 leukopheresis .k 53 to 477 1 to 426       426/426
(100 %)
5 diff
(98.9 %id)
BF515651   .k 155 to 570 1 to 416     Submitted on the opposite strand 416/416
(100 %)
0 diff
(100 %id)
DA465222   .l 1 to 565 2 to 566 exact tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
AI823947 2 pooled tumors (clear cell type), Kidney .l 119 to 322 204 to 1       204/204
(100 %)
0 diff
(100 %id)
DA594973 lung .m 1 to 574 2 to 575 exact tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
CN421965 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 1 to 723 725 to 1   tiling clone, Submitted on the opposite strand 725/725
(100 %)
6 diff
(99.2 %id)
T79080 liver and spleen .n 609 to 926 1 to 325   tiling clone,   325/329
(98 %)
16 diff
(95.2 %id)
T78601 liver and spleen .n 969 to 1460 521 to 4 R17Q E18G V19G I20Y L21P ... tiling clone,   518/573
(90 %)
31 diff
(94.6 %id)
R67399 placenta .o 1 to 353 1 to 363 exact tiling clone, Submitted on the opposite strand 363/364
(99 %)
16 diff
(95.7 %id)
R77903 placenta .o 1 to 378 1 to 388 exact tiling clone, Submitted on the opposite strand 388/388
(100 %)
13 diff
(96.7 %id)
AW572565 adenocarcinoma, Pancreas .p 1 to 449 1 to 449   tiling clone, Submitted on the opposite strand 449/449
(100 %)
1 diff
(99.8 %id)
BQ300812 bladder_tumor .p 394 to 989 628 to 34   tiling clone,   595/628
(94 %)
0 diff
(100 %id)
AV689757 hepatocellular carcinoma .p 929 to 1334 1 to 343       303/343
(88 %)
13 diff
(96.3 %id)
T85777 liver and spleen .p 962 to 1254 1 to 298   tiling clone,   298/319
(93 %)
7 diff
(97.9 %id)
TI_149291100   .p 1022 to 1694 758 to 89 F13X V14S T15P S16P N17T ... AAA   670/670
(100 %)
3 diff
(99.6 %id)
BM973847 lung .p 1044 to 1694 667 to 19   tiling clone, AAA   649/649
(100 %)
2 diff
(99.7 %id)
T91170 liver and spleen .p 1425 to 1687 263 to 1       263/265
(99 %)
2 diff
(99.3 %id)
T78538 liver and spleen .q-u 1 to 343 1 to 346 exact tiling clone, fully sequenced,   346/346
(100 %)
0 diff
(100 %id)
CB243931 Human Lung Epithelial cells, lung .q-u 49 to 786 755 to 19   AAA   737/737
(100 %)
3 diff
(99.6 %id)
AI870624 anaplastic oligodendroglioma, brain .q-u 163 to 786 645 to 22   AAA   624/624
(100 %)
0 diff
(100 %id)
AW002475 pooled germ cell tumors .q-u 163 to 786 635 to 7   tiling clone,   629/635
(99 %)
0 diff
(100 %id)
AI985221 colon, colonic mucosa from 3 patients with Crohn'sdisease .q-u 196 to 786 595 to 5       591/598
(98 %)
0 diff
(100 %id)
CA306125 Alveolar Macrophage, lung .q-u 197 to 786 609 to 19   AAA   591/591
(100 %)
3 diff
(99.5 %id)
AW972516   .q-u 199 to 784 586 to 1   tiling clone, Submitted on the opposite strand 586/625
(93 %)
0 diff
(100 %id)
T78465 liver and spleen .q-u 313 to 791 492 to 4   fully sequenced,   489/492
(99 %)
19 diff
(96.2 %id)
CN414594 embryonic stem cells, DMSO-treated H9 cellline .r-u 1 to 525 1 to 526 G40A tiling clone,   526/526
(100 %)
3 diff
(99.5 %id)
BG896218 cartilage .r-u 125 to 665 51 to 591   tiling clone,   541/591
(91 %)
6 diff
(99.0 %id)
AA077515 brain .r-u 355 to 601 1 to 249   tiling clone,   249/249
(100 %)
6 diff
(97.6 %id)
BF924790 nervous_tumor .s -10 to 227 238 to 1 T17A tiling clone, Submitted on the opposite strand 238/250
(95 %)
4 diff
(98.4 %id)
193 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r-u, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI